WVE

7.60

7.20% -0.59

Handel nachbörslich: 7.40 -0.20 -2.63%

Wave Life Sciences Ltd (WVE)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt WVE? Forum Prognose

Schlusskurs vom Vortag:

$8.19

Offen:

$8.28

24-Stunden-Volumen:

3.16M

Relative Volume:

1.56

Marktkapitalisierung:

$1.21B

Einnahmen:

$93.95M

Nettoeinkommen (Verlust:

$-129.87M

KGV:

-8.4444

EPS:

-0.9

Netto-Cashflow:

$-202.88M

1W Leistung:

+6.29%

1M Leistung:

+2.84%

6M Leistung:

+38.69%

1J Leistung:

-7.99%

1-Tages-Spanne:

$7.41

$8.28

1-Wochen-Bereich:

$7.07

$8.33

52-Wochen-Spanne:

$5.28

$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Firmenname

Wave Life Sciences Ltd

Sektor

Healthcare (1141)

Branche

Biotechnology (637)

Telefon

617-949-2900

Adresse

7 STRAITS VIEW, SINGAPORE

Mitarbeiter

288

Twitter

@WAVELifeSci

Nächster Verdiensttermin

2025-03-04

Neueste SEC-Einreichungen

WVE's Discussions on Twitter

Vergleichen Sie WVE mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
WVE Wave Life Sciences Ltd	7.60	1.30B	93.95M	-129.87M	-202.88M	-0.90
VRTX Vertex Pharmaceuticals Inc	407.79	106.37B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	460.46	59.90B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	564.63	60.40B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	796.92	49.56B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.10	36.88B	4.56B	-176.77M	225.30M	-1.7177

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-04	Eingeleitet	Canaccord Genuity	Buy
2025-07-28	Eingeleitet	Oppenheimer	Outperform
2025-07-16	Eingeleitet	Citigroup	Buy
2025-06-11	Fortgesetzt	Raymond James	Outperform
2025-04-29	Eingeleitet	Cantor Fitzgerald	Overweight
2025-04-08	Eingeleitet	Wedbush	Outperform
2025-02-25	Eingeleitet	Jefferies	Buy
2024-10-16	Hochstufung	Raymond James	Outperform → Strong Buy
2024-09-27	Fortgesetzt	JP Morgan	Overweight
2024-09-19	Eingeleitet	B. Riley Securities	Buy
2024-09-09	Eingeleitet	JP Morgan	Overweight
2024-05-15	Eingeleitet	Wells Fargo	Overweight
2023-12-19	Hochstufung	Leerink Partners	Market Perform → Outperform
2023-07-05	Eingeleitet	Raymond James	Outperform
2023-05-24	Herabstufung	Jefferies	Buy → Hold
2020-12-15	Fortgesetzt	H.C. Wainwright	Buy
2020-10-23	Eingeleitet	RBC Capital Mkts	Sector Perform
2019-12-31	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Eingeleitet	Guggenheim	Buy
2019-07-15	Eingeleitet	Cowen	Market Perform
2019-04-17	Bestätigt	H.C. Wainwright	Buy
2018-08-07	Eingeleitet	Stifel	Buy
2018-07-23	Eingeleitet	H.C. Wainwright	Buy
2018-03-19	Bestätigt	Mizuho	Buy
2017-02-15	Eingeleitet	H.C. Wainwright	Buy
2016-11-10	Fortgesetzt	Leerink Partners	Outperform
2015-12-07	Eingeleitet	JMP Securities	Mkt Outperform
2015-12-07	Eingeleitet	Jefferies	Buy
2015-12-07	Eingeleitet	Leerink Partners	Outperform
2015-12-07	Eingeleitet	Sun Trust Rbsn Humphrey	Buy

Alle ansehen

Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten

Oct 10, 2025

What the charts say about Wave Life Sciences Ltd. today2025 Investor Takeaways & Community Consensus Picks - newser.com

Oct 10, 2025

Full technical analysis of Wave Life Sciences Ltd. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com

Oct 10, 2025

Why analysts upgrade Wave Life Sciences Ltd. stock2025 Trading Volume Trends & Risk Managed Trade Strategies - newser.com

Oct 10, 2025

Strength Seen in Wave Life Sciences (WVE): Can Its 11.4% Jump Turn into More Strength? - Yahoo Finance

Oct 10, 2025

Has Wave Life Sciences Ltd. formed a bullish divergencePortfolio Gains Report & Low Risk High Win Rate Stock Picks - newser.com

Oct 10, 2025

Oct 09, 2025

What analysts say about Wave Life Sciences Ltd stockStop Loss Placement Tips & Discover Strategies with Fellow Traders - earlytimes.in

Oct 09, 2025

Wave Life Sciences Ltd 1U5 Stock Analysis and ForecastPortfolio Allocation Tips & Invest Now – Opportunity Window Closing - earlytimes.in

Oct 09, 2025

Will Wave Life Sciences Ltd. (1U5) stock enhance shareholder valueJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com

Oct 09, 2025

Why Wave Life Sciences Ltd. (1U5) stock is a strong buy callWeekly Loss Report & Reliable Trade Execution Plans - newser.com

Oct 09, 2025

Can technical indicators confirm Wave Life Sciences Ltd.’s reversalJuly 2025 Review & Expert Approved Momentum Ideas - newser.com

Oct 09, 2025

How Wave Life Sciences Ltd. (1U5) stock reacts to Fed tighteningQuarterly Risk Review & Low Volatility Stock Recommendations - newser.com

Oct 09, 2025

Oct 08, 2025

WAVE Life Sciences' (WVE) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 08, 2025

Oct 07, 2025

Wave Life Sciences Ltd. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges - Markets Mojo

Oct 07, 2025

Oct 06, 2025

Wave Life Sciences Ltd.’s volatility index tracking explainedJuly 2025 Opening Moves & Reliable Trade Execution Plans - newser.com

Oct 06, 2025

Is Wave Life Sciences Ltd. stock a contrarian buy2025 Price Targets & Low Drawdown Investment Strategies - newser.com

Oct 06, 2025

Key metrics from Wave Life Sciences Ltd.’s quarterly dataTrade Analysis Summary & Safe Entry Point Identification - newser.com

Oct 06, 2025

Oct 05, 2025

Will Wave Life Sciences Ltd. stock recover after recent dropMarket Trend Report & Weekly Market Pulse Alerts - newser.com

Oct 05, 2025

How Wave Life Sciences Ltd. stock benefits from strong dollarWeekly Investment Report & Reliable Entry Point Alerts - newser.com

Oct 05, 2025

Oct 03, 2025

Tools to monitor Wave Life Sciences Ltd. recovery probabilityQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com

Oct 03, 2025

Oct 02, 2025